KILITCH.NS
Price:
$335
Market Cap:
$5.86B
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nas...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-09-29
Stock Exchange
NSE
Ticker
KILITCH.NS
According to Kilitch Drugs (India) Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0. This represents a change of -100.00% compared to the average of 1.04 of the last 4 quarters.
The mean historical Current Ratio of Kilitch Drugs (India) Limited over the last ten years is 2.90. The current 0 Current Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), KILITCH.NS's Current Ratio was at its highest in in the March 2015 quarter at 6.82. The Current Ratio was at its lowest in in the June 2015 quarter at 0.
Average
2.90
Median
2.41
Minimum
1.10
Maximum
5.91
Discovering the peaks and valleys of Kilitch Drugs (India) Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.26%
Maximum Annual Current Ratio = 5.91
Minimum Annual Increase = -56.83%
Minimum Annual Current Ratio = 1.10
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.06 | -9.27% |
| 2024 | 2.27 | 23.87% |
| 2023 | 1.84 | 11.43% |
| 2022 | 1.65 | 50.26% |
| 2021 | 1.10 | -56.83% |
| 2020 | 2.54 | -21.36% |
| 2019 | 3.23 | -23.53% |
| 2018 | 4.22 | 1.66% |
| 2017 | 4.15 | -29.77% |
| 2016 | 5.91 | -13.25% |
The current Current Ratio of Kilitch Drugs (India) Limited (KILITCH.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.06
5-year avg
1.78
10-year avg
2.90
Kilitch Drugs (India) Limited’s Current Ratio is less than Ind-Swift Laboratories Limited (0), less than Ind-Swift Laboratories Limited (0), less than Venus Remedies Limited (0), less than Venus Remedies Limited (0), less than Wanbury Limited (0), less than Wanbury Limited (0), less than Sudarshan Pharma Industries Ltd. (1.19), less than Shree Ganesh Remedies Limited (4.00), less than Sakar Healthcare Limited (1.08), less than Kopran Limited (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0 | $7.07B | |
| 0 | $6.99B | |
| 0 | $10.15B | |
| 0 | $10.03B | |
| 0 | $7.82B | |
| 0 | $7.85B | |
| 1.19 | $6.31B | |
| 4.00 | $5.71B | |
| 1.08 | $8.20B | |
| 0 | $6.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kilitch Drugs (India) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kilitch Drugs (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Kilitch Drugs (India) Limited's Current Ratio?
How is the Current Ratio calculated for Kilitch Drugs (India) Limited (KILITCH.NS)?
What is the highest Current Ratio for Kilitch Drugs (India) Limited (KILITCH.NS)?
What is the 3-year average Current Ratio for Kilitch Drugs (India) Limited (KILITCH.NS)?
What is the 5-year average Current Ratio for Kilitch Drugs (India) Limited (KILITCH.NS)?
How does the current Current Ratio for Kilitch Drugs (India) Limited (KILITCH.NS) compare to its historical average?